Details for Patent: 10,188,546

Which drugs does patent 10,188,546 protect, and when does it expire?

Patent 10,188,546 protects MIUDELLA and is included in one NDA.

This patent has six patent family members in five countries.

Summary for Patent: 10,188,546

Title:	Intrauterine device with controlled copper ion elution
Abstract:	An intrauterine contraceptive device may include a frame made completely or partially of a first metal having a first galvanic potential and at least one metallic member coupled with the frame that is made of a second metal having a second galvanic potential different from the first galvanic potential. In some embodiments, the first galvanic potential may be more anodic than the second galvanic potential. In alternative embodiments, the first galvanic potential may be more cathodic than the second galvanic potential. In one embodiment, the first metal is Nitinol, and the second metal is copper. In some embodiments, the first and second galvanic potentials may be configured to achieve, at least approximately, a desired copper ion elution rate for the intrauterine device.
Inventor(s):	Michael Tal, Bob H. Katz, Scott M. Russell
Assignee:	Sebela Vlc Ltd
Application Number:	US14/289,530
Patent Claim Types: see list of patent claims	Delivery; Device;

Drugs Protected by US Patent 10,188,546

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sebela Womens Hlth	MIUDELLA	copper	SYSTEM;INTRAUTERINE	218201-001	Feb 24, 2025		RX	Yes	Yes			Y

International Family Members for US Patent 10,188,546

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014334932
Canada	2926210
European Patent Office	3057547
Mexico	2016004563
Mexico	2020001751
World Intellectual Property Organization (WIPO)	2015057291